Uğur Şahin, Founder Of BioNTech, Declares that mRNA can be used for rejuvenation

By  | 

With each and every clinical step forward, we are one step towards immortality, one of probably the most tricky targets we have now pursued for the reason that beginning of humanity. it is now not known whether we will be totally immortal within the long run, but consistent with a brand new explanation, to rejuvenate broken organs; therefore, it will likely be imaginable to increase the lifespan in the long run. the owner of the commentary is Prof.Dr., who has a great share within the production of a vaccine against COVID-19 with mRNA technology. Dr. Uğur Şahin.

Prof. Dr. Running because the CEO of BioNTech, which he co-based with Özlem Türeci, Prof. Dr. Uğur Şahin defined that damaged organs will also be regenerated and rejuvenated within the long run. the best way to do this is thru the mRNA approach, which saves millions of individuals from the wear and tear or even dying of the coronvirus.

mRNA can restore damaged organs

lucky şahin

Prof. Dr. Uğur Şahin spoke to the German newspaper Bild recently. Speaking approximately BioNTech’s current studies and conceivable long run studies, Şahin reminded that aging is a biological procedure and said that this procedure too can be encouraged from outdoor. consistent with the statements, it was already known years in the past that pores and skin cells can be reprogrammed by means of reprogramming with certain factors.

Uğur Şahin defined that this programming process can also be used on other organs with the mRNA method. Stating that the factors that result in regeneration may also be leaked into cells by the use of mRNA, the professor persevered his causes with the following phrases: “you can’t turn antique other folks into teens like in a science fiction film. However perhaps a broken heart or other broken or vintage organs are utterly or partly growing old. you can reverse the process.”

Özlem Türeci and Uğur Şahin’s corporate, BioNTech, is working on the utility of the fast development process for the COVID-19 vaccine to other remedy strategies. one in all the corporate’s subsequent objectives is to provide a COVID-19 vaccine with larger protection against variations inside of 100 days.

Uğur Şahin, Founder Latest - Uğur Şahin, Founder Suggestions

Uğur Şahin, Founder Detail - Uğur Şahin, Founder Properties

Leave a Reply

E-posta hesabınız yayımlanmayacak. Gerekli alanlar * ile işaretlenmişlerdir